プレマーケットデータ（自動更新なし）20日平均DV $205,270?
Earnings 2026-09-0252W high -57.7%52W low +76.5%Fwd PER 0.0xMarket cap $1MAvg volume 64K
Company Overview
NewcelX Ltd., a biotechnology company, engages in developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company was founded in 2008 and is headquartered in Zurich, Switzerland.
Earnings & Financials
Earnings actuals
| Period | EPS | Revenue | FCF |
|---|
| 2025 Q2 | -10.50 | $0 | -$2M |
| 2024 Q4 | -26.30 | $0 | -$3M |
| 2024 Q2 | 0.00 | $0 | -$2M |
| 2023 Q4 | -1.40 | $0 | -$2,387 |
| 2023 Q2 | -2.00 | $0 | -$7M |
| 2022 Q4 | -2.90 | $0 | -$6M |
| 2022 Q2 |
